ONDERO MET 2.5/1000MG TABLET is a combination medication containing Metformin and Linagliptin, both classified as Antidiabetic agents. Specifically designed for adult patients with type II diabetes mellitus, this medicine is recommended when traditional methods like diet, exercise, and other medications fail to sufficiently control blood sugar levels.

Type II diabetes mellitus is a condition characterized by high levels of glucose in the blood, resulting from insufficient insulin production by the pancreas or decreased sensitivity of body cells to insulin. ONDERO MET 2.5/1000MG TABLET acts as an adjunct therapy in such cases, working alongside lifestyle modifications to achieve better glucose control.

For optimal results, it is advisable to take ONDERO MET 2.5/1000MG TABLET with meals. Regular monitoring of blood sugar levels and kidney function may be necessary during the treatment to mitigate potential side effects. Patients with preexisting liver, kidney, or heart issues should disclose their medical history to the healthcare provider before starting this medication. Additionally, those facing blood circulation problems or severe dehydration due to recent vomiting or diarrhea should also seek medical advice.

This medication is not recommended for individuals with severely uncontrollable diabetes, alcoholism, or severe systemic infections. Pregnant or breastfeeding women should consult their doctor before initiating treatment. Common side effects of ONDERO MET 2.5/1000MG TABLET include nausea, diarrhea, stomach pain, constipation, loss of appetite, and a metallic taste in the mouth. It is important to communicate any bothersome side effects to the healthcare provider for appropriate management.